4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
House Committee Investigates Eli Lilly's Clinical Trials in China
The House Select Committee on the Chinese Communist Party is investigating Eli Lilly's clinical trials in China, particularly at military-affiliated hospitals and in Xinjiang. Chairman John Moolenaar has requested detailed information regarding ethical standards and protections for sensitive data, amid concerns over national security and human rights risks. Eli Lilly must respond to the committee's inquiries by July 17.
Our neutral summary
The House Select Committee on the Chinese Communist Party is investigating Eli Lilly's clinical trials in China, particularly at military-affiliated hospitals and in Xinjiang. Chairman John Moolenaar has requested detailed information regarding ethical standards and protections for sensitive data, amid concerns over national security and human rights risks. Eli Lilly must respond to the committee's inquiries by July 17.
Read the full story at Fox News — Politics ↗
The reporting belongs to
Fox News — Politics;
we don't reproduce it.